Diabetes, Obesity & Metabolism
Initiation of SGLT2 Inhibitors Versus DPP-4 Inhibitors in Metformin Users and Risk of Incident Depression: A Nationwide, Claims-Based Active-Comparator New-User Study
Cohort study of 38,297 peopleSGLT2 inhibitors
Papers by Soo-Jung Choi
2 results